Significant reduction in hemarthrosis in boys with severe hemophilia A: The China hemophilia individualized low‐dose secondary prophylaxis study

INTRODUCTION: In countries with restricted access to clotting factor concentrates, early implementation of low‐dose prophylaxis is recommended over episodic treatment. OBJECTIVE: The objective of this 1‐year prospective secondary prophylaxis study was to evaluate the efficacy of a dose/frequency esc...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Runhui, Li, Xiaojing, Yao, Wanru, Zhang, Qing, Zhou, Min, Zhang, Ningning, Yang, Sheng, Chen, Zhenping, Wang, Yan, Kuang, Yangying, Tang, Ling, Zhen, Yingzi, Abad, Audrey, Doria, Andrea S., Hilliard, Pamela, Ignas, Danial M., Mathew, Prasad, Stephens, Derek, Blanchette, Victor S., Luke, Koon‐Hung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8449287/
https://www.ncbi.nlm.nih.gov/pubmed/34568725
http://dx.doi.org/10.1002/rth2.12552

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8449287/
https://www.ncbi.nlm.nih.gov/pubmed/34568725
http://dx.doi.org/10.1002/rth2.12552

Ejemplares similares